Background Oncogenic human papillomavirus (HPV) infection prevalence is required to
determine optimal vaccination strategies. We systematically reviewed the prevalence of …

AIM: Clinical trials have shown prophylactic human papillomavirus (HPV) vaccines to be
effective against infection and disease. We examined whether HPV vaccination has the …

It has been suggested that human papillomavirus (HPV) testing improves follow‐up of
atypical cells of undetermined significance (ASCUS) and low‐grade squamous …

Objectives To systematically review the choice of comparator strategies in cost-effectiveness
analyses (CEAs) of human papillomavirus testing in cervical screening. Methods The …

Objective Low-grade squamous intraepithelial lesion (LSIL) Pap results do not typically lead
to human papillomavirus (HPV) testing. HPV triage is not cost-effective because most cases …

Background: Women with borderline/mildly dyskaryotic (BMD) cytology smears are currently
followed up with repeat testing at 6 and 18 months. The objective of this study is to analyse …

The type-specific persistence of oncogenic human papillomavirus (HPV) is considered to be
the true precursor of cervical cancer at which the transcription of the viral oncogenes E6 and …

Cervical screening reduces the risk of cervical cancer by detecting and treating cervical
intraepithelial neoplasia (CIN). The management of women with low-grade cervical …

In order to determine the release profile of 5–fluorouracil (5-FU) from modern
pharmaceutical dosage forms with vaginal administration during in vitro dissolution tests, an …

Objectives This study was to assess whether human papillomavirus (HPV) resulting in
genetic instability is one reason for the high incidence and mortality of cervical cancer in …